Total
0
Shares
Glow LifeTech (CSE:GLOW) files natural health product ArtemiC™ with Health Canada
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Glow LifeTech submitted an application to Health Canada to obtain produce licenses for its Natural Health Product (NHP), ArtemiC™
  • ArtemiC™ was submitted to Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) on Mar 11, 2021
  • With Health Canada approval and favourable clinical results, ArtemiC™ could become an all-natural solution to aid patient recovery
  • Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products
  • Glow LifeTech Corp. (GLOW) opened trading at C$0.54 per share

Relay Medical Corp (RELA), a shareholder of Glow LifeTech (GLOW) is pleased to provide an update on Glow LifeTech Corp.

On April 27, Glow submitted an application to Health Canada to obtain produce licenses for its Natural Health Product (NHP), ArtemiC™, which reported successful results from a COVID-19 Phase II clinical trial.

ArtemiC™ was submitted to Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) on Mar 11, 2021. The application, which is currently under review by Health Canada, included ArtemiC™, which Glow LifeTech received exclusive rights to in early February.

"Canada has the potential to set the world stage for COVID-19 Natural Health Products. With Health Canada approval and favorable clinical results, ArtemiC™ could become an evidence backed all-natural solution to aid patient recovery," stated Yoav Raiter, CEO, Relay Medical Corp.

"Glow has exclusive rights to market, sell, and distribute ArtemiC™ in Canada, the United States, Mexico, and all Caribbean countries as a food supplement (nutraceutical, dietary supplement, and natural health product)."

Glow LifeTech is a Canadian-based biotechnology company focused on producing nutraceutical and cannabinoid-based products.

Glow LifeTech Corp. (GLOW) opened trading at C$0.54 per share.

More From The Market Herald
VitalHub - President and CEO, Dan Matlow - The Market Herald Canada

" VitalHub (TSXV:VHI) to commence trading on the TSX

VitalHub (VHI) begins trading on the Toronto Stock Exchange on September 23, 2021.
BetterLife Pharma - CEO, Ahmad Doroudian. - The Market Herald Canada

" BetterLife (CSE:BETR) enrolls first patient in Interferon alpha-2b COVID-19 trial

The first patient has been enrolled in BetterLife’s (BETR) Interferon alpha-2b COVID-19 trial in Chile.
International Consolidated Uranium (TSXV:CUR) partners with Mars Investor Relations

" Algernon Pharmaceuticals (CSE:AGN) welcomes Dr. Mark Williams to the board

Algernon Pharmaceuticals (AGN) is pleased to announce that Dr. Mark Williams has been appointed as a member of the Board of Directors.
Small Pharma - CEO, Peter Rands (third from left) and the Small Pharma team. - The Market Herald Canada

" Negev Capital doubles down on Small Pharma (TSXV:DMT)

Negev Capital, a psychedelic medical intervention fund, has doubled its investment in Small Pharma (DMT).